Management
Ph.D. in Pharmacy. Experience with regulatory affairs, vaccine research and development and project management from the Medical Products Agency (Läkemedelsverket), SBL Vaccin, Active Biotech and Accuro Immunology.
Vice President, Torgny H. Svensson
M.D., Ph.D. Professor of Pharmacology and Vice Head of Research Chairman,
Karolinska Institutet, Member of the Nobel Assembly, Vice President
CINP 1998-present. President elect 2004. President Scandinavian College
of Neuro- Psychopharmacology. Member of the Scientific Advisory Boards
of Carnegie Health Care Funds and the University of Cagliari, Center
of Excellence "Neurobiology of the Addictions". Prof. Svensson
has received several national and international awards and he has about
250 publications in major scientific journals, including Science and
Nature.
Advisor Business Development, Jan Sandström
M.Sc Pharm., Senior VP, Business Development & Licensing, Biolipox
AB. Formerly VP Business Development & Patents, Astra and Director,
Global Licensing at AstraZeneca., Member of the Boards of Swedish Shareholder
Association and SARF Service AB
Advisor in Medical, Chemistry Per Månsson
Ph.D. in Chemistry, VP Biosensor and Vaccine Development Applications.
Previously with Pharmacia, Uppsala (Head of Chemistry, Head of discovery
and Head of new projects) and SBL Vaccine (Head of New Projects).
Scientific Clinical Advisor, Karl Olov Fagerström
Ph.D. in Medical Psychology. Previous Chairman of the Society for Research
on Nicotine and Tobacco Europe. Chairman of the American Society for
Research on Nicotine and Tobacco. Over 100 peer reviewed international
publications, mostly on tobacco dependence.
Project Team
Torgny H. Svensson, Head of research
Lena Degling Wikingsson, Project director
Nina Lindblom, Ph.D student., Pre-clinical Pharmacology
Sabina de Villiers, Ph.D student., Pre-clinical pharmacology
Per Månsson, Medicinal chemistry & vaccines